As we move toward the final stretch of the year, we are excited to share some key updates and milestones from across the Personalised Medicine (PM) Network:

Upcoming 2^nd International Moesgaard Conferenc on Personalised Medicine

Preparations are well underway for this year’s  2^nd International Moesgaard Conference on Personalised Medicine Conference, which will take place on 4-5 November 2025 at Moesgaard Muesum in Aarhus. Over two dynamic days, leading international and Danish experts will share cutting-edge insights across neuroscience, genetics, cancer research, diabetes etc. Whether you are a researcher, clinician, or industry representative this is great opportunity to engage with the forefront of personalised medicine. Highlights include:

• Keynotes from Sergiu Pasca (Stanford), Naomi Wray (Oxford), Ewan Pearson (Dundee), and Richard Dobson (King’s College London)
• Networking opportunities, poster sessions, and flash talks from emerging researchers
• A conference dinner to connect and collaborate
• Register, submit your abstract and see the full programme at the conference website: conferences.au.dk/international-conference-on-personalised-medicine

Danish Government’s 2025-2027 Strategy for Personalised Medicine

The upcoming Moesgaard conference is particularly timely given the 2025-2027 Strategy for Personalised Medicine recently announced by the Danish government. The 2025-2027 strategy builds on previous versions (2017-2020 and 2021-2022). In addition to incorporating genetic data, new technologies, artificial intelligence, biomarker data, health data, and lifestyle factors, personalised medicine should also account for patient needs and preferences. 

The 2025-2027 strategy defines personalised medicine as “an approach in healthcare where early detection, prevention, diagnosis, treatment, and follow-up are increasingly carried out in collaboration with the patient and thus tailored to and based on the individual’s unique profile and medical journey. This individualised approach enables the use of, among other things, health data and advanced technologies to create the most effective and targeted health-promoting interventions”. 

The strategy has seven goals:

1. Put the patient first – ensure that the patient’s preferences, values and life situation are considered when deciding on the prevention and treatment of a disease.
2. Strengthen the framework for research in personlised medicine enabling faster dissemination and translation of research findings to patient benefit.
3. Make Denmark a leader in advanced therapies, particularly in the development, testing, and use of advanced therapies to give Danish patients faster access to the most effectiveness treatments.
4. Enhance the resources and increase the quality of the healthcare system, thereby improving treatment quality to ensure a more cost-effective use of healthcare resources through data-supported targeting of prevention and treatment.
5. Strengthen Denmark’s biobanks and health databases so that data can be used more effectiely for the benefit of patients and facilitating research at the highest international level of excellence.
6. Improve the use of Danish health data and artificial intelligence to facilitate tailored treatments for individual patients.
7. Expand the use of personalised medicine across the healthcare system so that more patients gain benefit from personalised medicine advances.

More information on the 2025-2027 Strategy for Personalised Medicine can be found here (currently in Danish only): Strategi for personlig medicin 2025 - 2027

SmartBioMed Pioneer Center – Official Opening

On June 19, the International Pioneer Centre for SMARTbiomed (Statistical and Computational Methods for Advanced Research to Transform Biomedicine), which is a collaboration between Aarhus University, University of Copenhagen and Oxford University, was officially opened. SMARTbiomed will focus on development of statistical and computational methods on causal inference, risk prediction, and machine learning. The pioneer centre, which has received 250 million DKK from five major Danish foundations, is set to become a leading force in precision medicine – both nationally and internationally. Meet director of SMARTbiomed Naomi Wray at our upcoming PM conference in November.

We look forward to seeing many of you at the PM conference!

Anders Børglum & Deirdre Cronin Fenton, co-chairs of the Personalised Medicine Network